Skandinaviska Enskilda Banken AB publ Has $16.91 Million Position in Agilent Technologies, Inc. (NYSE:A)

Skandinaviska Enskilda Banken AB publ lessened its stake in Agilent Technologies, Inc. (NYSE:AFree Report) by 0.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 151,245 shares of the medical research company’s stock after selling 1,159 shares during the quarter. Skandinaviska Enskilda Banken AB publ’s holdings in Agilent Technologies were worth $16,912,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the stock. Money Concepts Capital Corp purchased a new position in Agilent Technologies in the 4th quarter valued at approximately $26,000. Hollencrest Capital Management grew its stake in Agilent Technologies by 562.5% in the 2nd quarter. Hollencrest Capital Management now owns 212 shares of the medical research company’s stock valued at $25,000 after buying an additional 180 shares in the last quarter. Ancora Advisors LLC purchased a new position in Agilent Technologies in the 4th quarter valued at approximately $34,000. OFI Invest Asset Management purchased a new position in Agilent Technologies in the 3rd quarter valued at approximately $25,000. Finally, Clearstead Trust LLC purchased a new position in Agilent Technologies in the 2nd quarter valued at approximately $30,000.

Wall Street Analysts Forecast Growth

A has been the subject of a number of recent research reports. Robert W. Baird reduced their price objective on shares of Agilent Technologies from $140.00 to $130.00 and set an “outperform” rating for the company in a research note on Tuesday, November 21st. TheStreet upgraded shares of Agilent Technologies from a “c+” rating to a “b-” rating in a research note on Friday, December 8th. JPMorgan Chase & Co. lifted their price objective on shares of Agilent Technologies from $140.00 to $165.00 and gave the company an “overweight” rating in a research note on Wednesday, December 20th. Wolfe Research began coverage on shares of Agilent Technologies in a research note on Wednesday, December 13th. They issued an “outperform” rating and a $140.00 price objective for the company. Finally, StockNews.com upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, December 19th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $137.44.

Read Our Latest Stock Analysis on A

Agilent Technologies Stock Performance

NYSE A opened at $133.34 on Friday. Agilent Technologies, Inc. has a 52-week low of $96.80 and a 52-week high of $155.75. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.97 and a current ratio of 2.61. The company has a market capitalization of $39.07 billion, a P/E ratio of 31.67, a P/E/G ratio of 3.04 and a beta of 1.11. The company has a fifty day moving average of $133.27 and a 200-day moving average of $122.06.

Agilent Technologies (NYSE:AGet Free Report) last posted its quarterly earnings data on Monday, November 20th. The medical research company reported $1.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.34 by $0.04. Agilent Technologies had a net margin of 18.15% and a return on equity of 28.24%. The company had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same period in the previous year, the firm posted $1.53 EPS. The firm’s revenue was down 8.7% compared to the same quarter last year. As a group, equities research analysts predict that Agilent Technologies, Inc. will post 5.48 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd were issued a dividend of $0.236 per share. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.23. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.71%. The ex-dividend date of this dividend was Friday, December 29th. Agilent Technologies’s payout ratio is currently 22.33%.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Michael R. Mcmullen sold 62,467 shares of the business’s stock in a transaction on Thursday, December 7th. The shares were sold at an average price of $130.00, for a total value of $8,120,710.00. Following the completion of the sale, the chief executive officer now directly owns 306,206 shares of the company’s stock, valued at $39,806,780. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Agilent Technologies news, VP Rodney Gonsalves sold 1,500 shares of the business’s stock in a transaction on Monday, December 18th. The shares were sold at an average price of $137.69, for a total value of $206,535.00. Following the completion of the sale, the vice president now directly owns 26,133 shares of the company’s stock, valued at $3,598,252.77. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Michael R. Mcmullen sold 62,467 shares of the business’s stock in a transaction on Thursday, December 7th. The stock was sold at an average price of $130.00, for a total transaction of $8,120,710.00. Following the completion of the sale, the chief executive officer now directly owns 306,206 shares of the company’s stock, valued at $39,806,780. The disclosure for this sale can be found here. In the last ninety days, insiders sold 95,929 shares of company stock valued at $12,730,599.

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Featured Stories

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.